Cargando…
Altered Serum Acylcarnitines Profile after a Prolonged Stay in Intensive Care
A stay in intensive care unit (ICU) exposes patients to a risk of carnitine deficiency. Moreover, acylated derivates of carnitine (acylcarnitines, AC) are biomarkers for metabolic mitochondrial dysfunction that have been linked to post-ICU disorders. This study aimed to describe the AC profile of su...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912811/ https://www.ncbi.nlm.nih.gov/pubmed/35268097 http://dx.doi.org/10.3390/nu14051122 |
_version_ | 1784667250420088832 |
---|---|
author | Rousseau, Anne-Françoise Schmitz, Sarah Cavalier, Etienne Misset, Benoit Boemer, François |
author_facet | Rousseau, Anne-Françoise Schmitz, Sarah Cavalier, Etienne Misset, Benoit Boemer, François |
author_sort | Rousseau, Anne-Françoise |
collection | PubMed |
description | A stay in intensive care unit (ICU) exposes patients to a risk of carnitine deficiency. Moreover, acylated derivates of carnitine (acylcarnitines, AC) are biomarkers for metabolic mitochondrial dysfunction that have been linked to post-ICU disorders. This study aimed to describe the AC profile of survivors of a prolonged ICU stay (≥7 days). Survivors enrolled in our post-ICU clinic between September 2020 and July 2021 were included. Blood analysis was routinely performed during the days after ICU discharge, focusing on metabolic markers and including AC profile. Serum AC concentrations were determined by LC-MS/MS and were compared to the reference ranges (RR) established from serum samples of 50 non-hospitalized Belgian adults aged from 18 to 81 years. A total 162 patients (65.4% males, age 67 (58.7–73) years) survived an ICU stay of 9.7 (7.1–19.3) days and were evaluated 5 (3–8) days after discharge. Their AC profile was significantly different compared to RR, mostly in terms of short chain AC: the sum of C3, C4 and C5 derivates reached 1.36 (0.98–1.99) and 0.86 (0.66–0.99) µmol/L respectively (p < 0.001). Free carnitine (C0) concentration of survivors (46.06 (35.04–56.35) µmol/L) was similar to RR (43.64 (36.43–52.96) µmol/L) (p = 0.55). C0 below percentile 2.5 of RR was observed in 6/162 (3.7%) survivors. Their total AC/C0 ratio was 0.33 (0.22–0.42). A ratio above 0.4 was observed in 45/162 (27.8%) patients. In ICU survivors, carnitine deficiency was rare, but AC profile was altered and AC/C0 ratio was abnormal in more than 25%. The value of AC profile as a marker of post-ICU dysmetabolism needs further investigations. |
format | Online Article Text |
id | pubmed-8912811 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89128112022-03-11 Altered Serum Acylcarnitines Profile after a Prolonged Stay in Intensive Care Rousseau, Anne-Françoise Schmitz, Sarah Cavalier, Etienne Misset, Benoit Boemer, François Nutrients Article A stay in intensive care unit (ICU) exposes patients to a risk of carnitine deficiency. Moreover, acylated derivates of carnitine (acylcarnitines, AC) are biomarkers for metabolic mitochondrial dysfunction that have been linked to post-ICU disorders. This study aimed to describe the AC profile of survivors of a prolonged ICU stay (≥7 days). Survivors enrolled in our post-ICU clinic between September 2020 and July 2021 were included. Blood analysis was routinely performed during the days after ICU discharge, focusing on metabolic markers and including AC profile. Serum AC concentrations were determined by LC-MS/MS and were compared to the reference ranges (RR) established from serum samples of 50 non-hospitalized Belgian adults aged from 18 to 81 years. A total 162 patients (65.4% males, age 67 (58.7–73) years) survived an ICU stay of 9.7 (7.1–19.3) days and were evaluated 5 (3–8) days after discharge. Their AC profile was significantly different compared to RR, mostly in terms of short chain AC: the sum of C3, C4 and C5 derivates reached 1.36 (0.98–1.99) and 0.86 (0.66–0.99) µmol/L respectively (p < 0.001). Free carnitine (C0) concentration of survivors (46.06 (35.04–56.35) µmol/L) was similar to RR (43.64 (36.43–52.96) µmol/L) (p = 0.55). C0 below percentile 2.5 of RR was observed in 6/162 (3.7%) survivors. Their total AC/C0 ratio was 0.33 (0.22–0.42). A ratio above 0.4 was observed in 45/162 (27.8%) patients. In ICU survivors, carnitine deficiency was rare, but AC profile was altered and AC/C0 ratio was abnormal in more than 25%. The value of AC profile as a marker of post-ICU dysmetabolism needs further investigations. MDPI 2022-03-07 /pmc/articles/PMC8912811/ /pubmed/35268097 http://dx.doi.org/10.3390/nu14051122 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rousseau, Anne-Françoise Schmitz, Sarah Cavalier, Etienne Misset, Benoit Boemer, François Altered Serum Acylcarnitines Profile after a Prolonged Stay in Intensive Care |
title | Altered Serum Acylcarnitines Profile after a Prolonged Stay in Intensive Care |
title_full | Altered Serum Acylcarnitines Profile after a Prolonged Stay in Intensive Care |
title_fullStr | Altered Serum Acylcarnitines Profile after a Prolonged Stay in Intensive Care |
title_full_unstemmed | Altered Serum Acylcarnitines Profile after a Prolonged Stay in Intensive Care |
title_short | Altered Serum Acylcarnitines Profile after a Prolonged Stay in Intensive Care |
title_sort | altered serum acylcarnitines profile after a prolonged stay in intensive care |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912811/ https://www.ncbi.nlm.nih.gov/pubmed/35268097 http://dx.doi.org/10.3390/nu14051122 |
work_keys_str_mv | AT rousseauannefrancoise alteredserumacylcarnitinesprofileafteraprolongedstayinintensivecare AT schmitzsarah alteredserumacylcarnitinesprofileafteraprolongedstayinintensivecare AT cavalieretienne alteredserumacylcarnitinesprofileafteraprolongedstayinintensivecare AT missetbenoit alteredserumacylcarnitinesprofileafteraprolongedstayinintensivecare AT boemerfrancois alteredserumacylcarnitinesprofileafteraprolongedstayinintensivecare |